Status:

COMPLETED

Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms.

Lead Sponsor:

S.LAB (SOLOWAYS)

Collaborating Sponsors:

Triangel Scientific

Center of New Medical Technologies

Conditions:

Hyperhomocysteinemia

Hyperlipoproteinemias

Eligibility:

All Genders

40-75 years

Phase:

NA

Brief Summary

This randomized, double-blind, placebo-controlled trial will evaluate the impact of methylfolate, pyridoxal-5'-phosphate (P5P), and methylcobalamin supplementation on homocysteine and LDL-C levels in ...

Detailed Description

Design: Participants with specific genetic polymorphisms and homocysteine levels above 15 µmol/L, without a history of severe CVD or other exclusion criteria, will be enrolled and randomized into two ...

Eligibility Criteria

Inclusion

  • Age between 40 and 75.
  • Homocysteine levels greater than 15 µmol/L and LDL-C level between 70 and 190 mg/dL, confirmed in at least two sequential checks conducted within the last six months prior to signing the consent form.
  • Presence of at least one minor allele in any of the following genetic polymorphisms: rs1801133 (MTHFR C677T), rs1801131 (MTHFR A1298C), rs1805087 (MTR A2756G), and rs1801394 (MTRR A66G).

Exclusion

  • Personal history of cardiovascular disease or high risk (≥ 20%).
  • Triglycerides (TG) ≥ 400 mg/dL.
  • Obesity (Body Mass Index \> 32 kg/m\^2).
  • Assumption of lipid-lowering drugs or supplements affecting lipid metabolism within the last three months.
  • Use of medications or supplements known to affect homocysteine levels, such as B-vitamins and certain antihypertensives, within the last three months.
  • Diabetes mellitus.
  • Known severe or uncontrolled thyroid, liver, renal, or muscle diseases.

Key Trial Info

Start Date :

March 2 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2023

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT06163443

Start Date

March 2 2022

End Date

May 1 2023

Last Update

March 27 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Center of New Medical Technologies

Novosibirsk, Novosibirsk Oblast, Russia, 630090